Hepatitis C

Citations 11-20 of 99 total displayed.

Hepatitis
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt

D Marzouk, J Sass, I Bakr, M El Hosseiny, M Abdel-Hamid, C Rekacewicz, N Chaturvedi, M K Mohamed, and A Fontanet
Gut 2007 56: 1105 -1110; published online before print as 10.1136/gut.2006.091983 [Abstract] [Full text] [PDF] [Request Permissions]  

Liver
Rapid and early virological response to chronic hepatitis C treatment with IFN 2b or PEG-IFN 2b plus ribavirin in HIV/HCV co-infected patients

Christopher Payan, Adeline Pivert, Patrice Morand, Samira Fafi-Kremer, Fabrice Carrat, Stanislas Pol, Patrice Cacoub, Christian Perronne, Françoise Lunel, and the ANRS HC02 RIBAVIC study team
Gut 2007 56: 1111 -1116; published online before print as 10.1136/gut.2006.106690 [Abstract] [Full text] [PDF] [Request Permissions]  

Liver disease
µ-Opioid receptor activation prevents acute hepatic inflammation and cell death

Dania Chakass, David Philippe, Edmone Erdual, Sébastien Dharancy, Mathilde Malapel, Caroline Dubuquoy, Xavier Thuru, Jerome Gay, Claire Gaveriaux-Ruff, Pierre Dubus, Philippe Mathurin, Brigitte L Kieffer, Pierre Desreumaux, and Mathias Chamaillard
Gut 2007 56: 974 -981; published online before print as 10.1136/gut.2006.105122 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Heterozygous ß-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C

Massimo Sartori, Silvano Andorno, Michela Pagliarulo, Cristina Rigamonti, Cristina Bozzola, Patrizia Pergolini, Roberta Rolla, Anna Suno, Renzo Boldorini, Giorgio Bellomo, and Emanuele Albano
Gut 2007 56: 693 -698; published online before print as 10.1136/gut.2006.106641 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatitis
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Nai-Jen Hou, Li-Po Lee, Ming-Yen Hsieh, Chang-Fu Chiu, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, and Wan-Long Chuang
Gut 2007 56: 553 -559; published online before print as 10.1136/gut.2006.102558 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy

Liana Codes, Tarik Asselah, Dominique Cazals-Hatem, Florence Tubach, Dominique Vidaud, Raymundo Paraná, Pierre Bedossa, Dominique Valla, and Patrick Marcellin
Gut 2007 56: 390 -395; published online before print as 10.1136/gut.2006.101931 [Abstract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

M Sherman, E M Yoshida, M Deschenes, M Krajden, V G Bain, K Peltekian, F Anderson, K Kaita, S Simonyi, R Balshaw, S S Lee the Canadian Pegasys Study Group
Gut 2006 55: 1631 -1638; published online before print as 10.1136/gut.2005.083113 [Abstract] [Full text] [PDF] [Request Permissions] [ Competing interests ]  

Article
Guidelines on the management of ascites in cirrhosis

K P Moore and G P Aithal
Gut 2006; 55: vi1-12vi. [Extract] [Full text] [PDF] [Request Permissions]  

Hepatitis
Cost effectiveness of interferon or peginterferon with ribavirin for histologically mild chronic hepatitis C

R Grieve, J Roberts, M Wright, M Sweeting, D DeAngelis, W Rosenberg, M Bassendine, J Main, and H Thomas
Gut 2006 55: 1332 -1338; published online before print as 10.1136/gut.2005.064774 [Abstract] [Full text] [PDF] [Request Permissions]  

Recent advances in clinical practice
Treating viral hepatitis C: efficacy, side effects, and complications

M P Manns, H Wedemeyer, and M Cornberg
Gut 2006; 55: 1350-1359. [Extract] [Full text] [PDF] [Request Permissions] [ Conflict of Interest ]